<document id="DDI-DrugBank.d324">
    <sentence id="DDI-DrugBank.d324.s16" text="Multiple-dose administration of the potent CYP3A4 inducer rifampin (600 mg every 24 hours, q24h, for 14 days), however, reduced zaleplon Cmax and AUC by approximately 80%.">
        <entity charOffset="58-65" id="DDI-DrugBank.d324.s16.e0" text="rifampin" type="drug" />
        <entity charOffset="128-135" id="DDI-DrugBank.d324.s16.e1" text="zaleplon" type="drug" />
        <pair ddi="true" e1="DDI-DrugBank.d324.s16.e0" e2="DDI-DrugBank.d324.s16.e1" id="DDI-DrugBank.d324.s16.p0" type="mechanism" />
    </sentence>
    <sentence id="DDI-DrugBank.d324.s22" text="Other strong selective CYP3A4 inhibitors such as ketoconazole can also be expected to increase the exposure of zaleplon.">
        <entity charOffset="49-60" id="DDI-DrugBank.d324.s22.e0" text="ketoconazole" type="drug" />
        <entity charOffset="111-118" id="DDI-DrugBank.d324.s22.e1" text="zaleplon" type="drug" />
        <pair ddi="true" e1="DDI-DrugBank.d324.s22.e0" e2="DDI-DrugBank.d324.s22.e1" id="DDI-DrugBank.d324.s22.p0" type="mechanism" />
    </sentence>
    </document>